top of page
Executive Spotlights

Arch Ventures-incubated clinical trials startup leaves stealth with $203M

Chicago, January 27, 2023 (Yahoo) -- The Food and Drug Administration increasingly requires that drug trials are tested on population samples reflective of the people who will use the drug, according to Rebecca Springer, a PitchBook senior healthcare analyst. Paradigm, a clinical trial technology startup, launched out of stealth with a $203 million Series A Friday with hopes to bring research trials to all US patients. The funding slots in as the eighth-largest early-stage healthtech VC deal ever, PitchBook data shows.


Read full article here.

Recent Posts

See All

AxoSim appoints Alif Saleh as CEO

New Orleans, LA, June 14, 2024 (Indian Pharma Post) -- AxoSim, a life science firm specializing in lab-grown human brains, has appointed Alif Saleh as its new CEO. Salef, a company builder, brings e

Comments


Life Science Headlines
bottom of page